![Sarabjot Pabla Profile](https://pbs.twimg.com/profile_images/1401301049256841217/Vud9GxuH_x96.jpg)
Sarabjot Pabla
@PablaSabi
Followers
203
Following
333
Statuses
397
Genomic Medicine leader working at the cutting edge of immuno-oncology. Tweets: my opinions. https://t.co/PvxBxWNkri
Joined March 2017
Our work on integrating tumor inflammation and proliferation biomarkers in solid tumors is out. Read more here: @OmniSeq #cancerresearch #immunotherapy #immunooncology #oncology #oncologyresearch #oncologyclinicalresearch
0
4
9
RT @Sarbaji85064063: Hot off the press! In collaboration with @OmniSeq, our new study highlights the potential role of Cancer Testis Antige…
0
5
0
Check out my latest article: CSF-based liquid biopsy in Pediatric Neuro-Oncology via @LinkedIn
0
2
2
Check out my latest article: The Role of HLA Loss in Cancer Biology: Immune Evasion and Therapeutic Implications via @LinkedIn
0
2
3
RT @oncodaily: Our latest molecular tumor board with a case of recurrent HCC - @PablaSabi
#Cancer #Immunotherapy…
0
5
0
Check out my latest article: Macrophage Makeover: New Drug Targets Turning Dual-Natured Immune Cells into Cancer-Fighting Superstars! via @LinkedIn
0
1
2
Check out my latest article: Tumor Board Review: Remarkable response to immunotherapy via @LinkedIn
0
2
2
RT @oncodaily: Did you know that the Receiver-operating characteristic (ROC) actually traces its roots back to World War II? - @PablaSabi…
0
3
0
Check out my latest article: Tackling the Toughest Challenges in Solid Tumor Treatment via @LinkedIn
0
2
2
RT @TiansterZhang: Overall survival has been hard to show in #kidneycancer. Grateful to have contributed to #Keynote564 while @DukeGUCancer…
0
10
0
New #research shows that dying #tumor cells can suppress the anti-cancer #immune response, potentially hindering the effectiveness of #immunotherapy. #cancer #oncology #immunptherapy #immuneresponse #cancerresearch Learn more about this study.
0
0
0
RT @oncodaily: What an incredible opportunity it was to be part of AACR2024 - @PablaSabi
@rjafijneman @AACR
#AACR #CancerResearch #Canc…
0
3
0